Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Summary

This phase II trial studies how well lapatinib ditosylate works in treating patients with metastatic or recurrent head and neck cancer. Lapatinib ditosylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Timeline

Start

2005-03

Primary completion

2006-10

Completion

2006-10

Drugs

Indications